MX361733B - Derivados antibacterianos del 2h-indazol. - Google Patents
Derivados antibacterianos del 2h-indazol.Info
- Publication number
- MX361733B MX361733B MX2016003196A MX2016003196A MX361733B MX 361733 B MX361733 B MX 361733B MX 2016003196 A MX2016003196 A MX 2016003196A MX 2016003196 A MX2016003196 A MX 2016003196A MX 361733 B MX361733 B MX 361733B
- Authority
- MX
- Mexico
- Prior art keywords
- antibacterial
- indazole derivatives
- halogen
- indazole
- derivatives
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
- C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a los compuestos antibacterianos de la fórmula I (ver Fórmula) en donde R1 es H o halógeno; R2 es alquiniloxi o el grupo M; R3 es H o halógeno; M es uno de los grupos (ver Fórmulas) en donde A es un enlace, CH2CH2, CH=CH o C?C y R1A, R2A, R3A, R1B y R1C son tal como se define en la reivindicación 1; y sales de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2013058537 | 2013-09-13 | ||
| PCT/IB2014/064458 WO2015036964A1 (en) | 2013-09-13 | 2014-09-12 | Antibacterial 2h-indazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016003196A MX2016003196A (es) | 2016-06-02 |
| MX361733B true MX361733B (es) | 2018-12-14 |
Family
ID=51688371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016003196A MX361733B (es) | 2013-09-13 | 2014-09-12 | Derivados antibacterianos del 2h-indazol. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9802901B2 (es) |
| EP (1) | EP3044211B1 (es) |
| JP (1) | JP6353909B2 (es) |
| KR (1) | KR20160055889A (es) |
| CN (1) | CN105531264B (es) |
| AR (1) | AR097617A1 (es) |
| AU (1) | AU2014319966B2 (es) |
| BR (1) | BR112016007757A8 (es) |
| CA (1) | CA2923146A1 (es) |
| CL (1) | CL2016000568A1 (es) |
| CY (1) | CY1120111T1 (es) |
| DK (1) | DK3044211T3 (es) |
| EA (1) | EA031562B1 (es) |
| ES (1) | ES2662894T3 (es) |
| HR (1) | HRP20180484T1 (es) |
| HU (1) | HUE038519T2 (es) |
| IL (1) | IL244500B (es) |
| LT (1) | LT3044211T (es) |
| MA (1) | MA38948B1 (es) |
| MX (1) | MX361733B (es) |
| MY (1) | MY179283A (es) |
| PH (1) | PH12016500480A1 (es) |
| PL (1) | PL3044211T3 (es) |
| PT (1) | PT3044211T (es) |
| SG (1) | SG11201601889YA (es) |
| SI (1) | SI3044211T1 (es) |
| TW (1) | TWI646084B (es) |
| UA (1) | UA116484C2 (es) |
| WO (1) | WO2015036964A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014368619B2 (en) | 2013-12-19 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Antibacterial 1H-indazole and 1H-indole derivatives |
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| ES2687040T3 (es) | 2014-05-16 | 2018-10-23 | Idorsia Pharmaceuticals Ltd | Derivados antibacterianos de quinazolin4(3H)ona |
| SG11201703992YA (en) | 2014-11-19 | 2017-06-29 | Actelion Pharmaceuticals Ltd | Antibacterial benzothiazole derivatives |
| AR105646A1 (es) * | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
| EA201890600A1 (ru) * | 2015-08-28 | 2018-09-28 | Идорсиа Фармасьютиклз Лтд | Антибактериальные аннелированные производные пирролидин-2-она |
| AR105848A1 (es) * | 2015-08-31 | 2017-11-15 | Actelion Pharmaceuticals Ltd | Derivados heterocíclicos antibacterianos |
| AR105889A1 (es) * | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
| TW201741308A (zh) * | 2016-05-17 | 2017-12-01 | 愛杜西亞製藥有限公司 | 6-(丁-1,3-二炔-1-基)苯并[d]噻唑衍生物 |
| WO2019038362A1 (en) | 2017-08-24 | 2019-02-28 | Idorsia Pharmaceuticals Ltd | ANTIBACTERIAL PYRROLOIMIDAZOLONES |
| CN113372276B (zh) * | 2021-05-25 | 2022-04-22 | 三峡大学 | 吲唑类衍生物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ533282A (en) | 2001-12-05 | 2006-09-29 | Ortho Mcneil Pharm Inc | 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials |
| US6806279B2 (en) | 2001-12-17 | 2004-10-19 | Sunesis Pharmaceuticals, Inc. | Small-molecule inhibitors of interleukin-2 |
| SG2013013339A (en) | 2002-03-13 | 2014-12-30 | Array Biopharma Inc | N3 alkylated benzimidazole derivatives as mek inhibitors |
| DE102004017930A1 (de) | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| MX2007006961A (es) | 2004-12-10 | 2007-10-04 | Univ Emory | Analogos nucleosidos de ciclobutilo 2' y 3'-sustituidos para el tratamiento de infeccciones virales y proliferacion celular anormal. |
| DE602006012815D1 (de) | 2005-03-23 | 2010-04-22 | Hoffmann La Roche | Acetylenylpyrazolopyrimidinderivate als mglur2-antagonsten |
| JP5539864B2 (ja) | 2007-06-12 | 2014-07-02 | アカオゲン，インコーポレーテッド | 抗菌剤 |
| DE102008044132A1 (de) | 2008-11-27 | 2010-06-02 | BSH Bosch und Siemens Hausgeräte GmbH | Kältegerät mit zweiseitig anschlagbarer Tür |
| WO2010100475A1 (en) | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Hydroxamic acid derivatives as gram-negative antibacterial agents |
| EP2432468A2 (en) | 2009-05-20 | 2012-03-28 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
| EP2451790A4 (en) | 2009-07-07 | 2012-12-26 | Anthem Biosciences Private Ltd | INHIBITORS OF HISTONE DEACETYLASE |
| WO2011045703A2 (en) * | 2009-10-13 | 2011-04-21 | Pfizer Inc. | C-linked hydroxamic acid derivatives useful as antibacterial agents |
| DK2512474T3 (en) | 2009-12-16 | 2014-12-01 | Pfizer | N-linked hydroxamic acid derivatives which can be used as antibacterial agents |
| GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| EA201390626A1 (ru) | 2010-11-10 | 2013-12-30 | Эйкеоджен, Инк. | Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций |
| US8853213B2 (en) | 2011-01-03 | 2014-10-07 | Hanmi Pharm. Co., Ltd | Bicyclic compound for modulating G protein-coupled receptors |
| MA34963B1 (fr) | 2011-03-07 | 2014-03-01 | Pfizer | Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens |
| CA2830866A1 (en) * | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| WO2012137094A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Isoxazole derivatives useful as antibacterial agents |
| EP2847162A1 (en) | 2012-05-09 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
| AU2014368619B2 (en) | 2013-12-19 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Antibacterial 1H-indazole and 1H-indole derivatives |
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| ES2687040T3 (es) | 2014-05-16 | 2018-10-23 | Idorsia Pharmaceuticals Ltd | Derivados antibacterianos de quinazolin4(3H)ona |
-
2014
- 2014-09-10 AR ARP140103376A patent/AR097617A1/es unknown
- 2014-09-12 EA EA201600248A patent/EA031562B1/ru not_active IP Right Cessation
- 2014-09-12 ES ES14781948.6T patent/ES2662894T3/es active Active
- 2014-09-12 TW TW103131666A patent/TWI646084B/zh not_active IP Right Cessation
- 2014-09-12 PT PT147819486T patent/PT3044211T/pt unknown
- 2014-09-12 LT LTEP14781948.6T patent/LT3044211T/lt unknown
- 2014-09-12 US US15/021,649 patent/US9802901B2/en not_active Expired - Fee Related
- 2014-09-12 PL PL14781948T patent/PL3044211T3/pl unknown
- 2014-09-12 EP EP14781948.6A patent/EP3044211B1/en not_active Not-in-force
- 2014-09-12 HU HUE14781948A patent/HUE038519T2/hu unknown
- 2014-09-12 AU AU2014319966A patent/AU2014319966B2/en not_active Ceased
- 2014-09-12 MX MX2016003196A patent/MX361733B/es active IP Right Grant
- 2014-09-12 DK DK14781948.6T patent/DK3044211T3/en active
- 2014-09-12 SG SG11201601889YA patent/SG11201601889YA/en unknown
- 2014-09-12 HR HRP20180484TT patent/HRP20180484T1/hr unknown
- 2014-09-12 WO PCT/IB2014/064458 patent/WO2015036964A1/en not_active Ceased
- 2014-09-12 JP JP2016542426A patent/JP6353909B2/ja not_active Expired - Fee Related
- 2014-09-12 BR BR112016007757A patent/BR112016007757A8/pt not_active Application Discontinuation
- 2014-09-12 KR KR1020167009718A patent/KR20160055889A/ko not_active Ceased
- 2014-09-12 MY MYPI2016700850A patent/MY179283A/en unknown
- 2014-09-12 SI SI201430662T patent/SI3044211T1/en unknown
- 2014-09-12 CA CA2923146A patent/CA2923146A1/en not_active Abandoned
- 2014-09-12 MA MA38948A patent/MA38948B1/fr unknown
- 2014-09-12 CN CN201480049877.8A patent/CN105531264B/zh not_active Expired - Fee Related
- 2014-12-09 UA UAA201603879A patent/UA116484C2/uk unknown
-
2016
- 2016-03-08 IL IL244500A patent/IL244500B/en not_active IP Right Cessation
- 2016-03-10 CL CL2016000568A patent/CL2016000568A1/es unknown
- 2016-03-11 PH PH12016500480A patent/PH12016500480A1/en unknown
-
2018
- 2018-03-30 CY CY20181100362T patent/CY1120111T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500480B1 (en) | Antibacterial 2h-indazole derivatives | |
| SA516371717B1 (ar) | مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا | |
| CY1120173T1 (el) | Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης | |
| EA201591503A1 (ru) | Производные нафтиридина, полезные в качестве антагонистов альфа-v-бета-6 интегрина | |
| PH12016500225B1 (en) | Novel quinoline-substituted compound | |
| PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
| CR20150470A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
| EA201691194A1 (ru) | Стимуляторы ргц | |
| UA116395C2 (uk) | ПОХІДНІ ТРИАЗОЛ[4,5-b]ПІРИМІДИНУ | |
| CR20140306A (es) | Fluormetil -5,6-dihidro-4h-[1,3] oxazinas | |
| MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
| EA201690894A1 (ru) | Феноксиэтилы | |
| EA201790627A1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
| JO3318B1 (ar) | مثبطات bace | |
| PH12016502253A1 (en) | Antibacterial quinazoline-4(3h)-one derivatives | |
| CR20150417A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| MX2016002718A (es) | Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc). | |
| EA201690227A1 (ru) | Азаиндольные соединения, их получение и способы их применения | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| MX2015007309A (es) | Derivado de hidantoina. | |
| MX2015016766A (es) | Nuevos derivados de tetrazolona. | |
| MX2018014170A (es) | Derivados 6-(buta-1,3-diin-1-il)benzo[d]tiazol. | |
| CY1120482T1 (el) | Μεθοδος συνθεσης 3,4-διμεθοξυδικυκλο[4.2.0]οκτα-1,3,5-τριενο-7-καρβονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξy | |
| JO3298B1 (ar) | مشتقات جليكوبيرانوسيل-مستبدل و اندول-يوريا و استعمالاتهم كمثبطات sglt | |
| MX2015009377A (es) | Compuestos radiomarcados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: IDORSIA PHARMACEUTICALS LTD |
|
| FG | Grant or registration |